AVIENCE BIOMEDICALS LTD (AVIENCE-SM) Share Price Rises 10% to Rs 376.25

Published: 28 September 2026 at 11:52:25 AM IST

AVIENCE BIOMEDICALS Share Price rose to Rs 376.25 today, up 10.00% from the previous close of Rs 342.05. The stock added Rs 34.20 in a single session, and the session high matched the closing level at Rs 376.25. Market capitalisation stood at Rs 187.62 crore, while turnover was Rs 3.57 crore. The supplied data confirms a strong price move, but it does not identify any company-specific announcement, operational trigger or external event behind the rise. That distinction matters because a sharp share price move can reflect market interest, but the reason for the move must remain limited to verified inputs. For readers tracking AVIENCE BIOMEDICALS Share Price Today, the day’s update is therefore best read as a factual market event with sector and peer context rather than as a commentary on an undisclosed catalyst.

AVIENCE BIOMEDICALS Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 376.25
Previous Close	Rs 342.05
Today's Move	Rs 34.2 (+10%)
Open	Rs 346
High	Rs 376.25
Low	Rs 333
Turnover	Rs 3.57 crore
Market Capitalisation	Rs 187.62 crore
Market Cap Category	Micro Cap

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) rose to Rs 376.25 from the previous close of Rs 342.05, a move of Rs 34.2 or 10%. The stock opened at Rs 346, reached a high of Rs 376.25, recorded a low of Rs 333.

Price action was the most important part of today’s update. AVIENCE BIOMEDICALS LTD opened at Rs 346 and quickly traded through a wide intraday range between Rs 333 and Rs 376.25. The stock ultimately finished at the day high, which suggests that buying interest remained present through the close. That is an observable market outcome, not a forecast, but it does show that the gain was sustained rather than fading into the session end.

The move also stood out relative to the previous close. AVIENCE BIOMEDICALS Share Price increased by 10% on the day, which is large enough to place the stock among notable market movers. Because the close was identical to the high, the last traded level also represented the strongest point of the session. In practical terms, that leaves investors with a clean price action read: the stock did not just spike briefly, it retained its gains through the closing print.

Turnover of Rs 3.57 crore gives a further factual reference point. It shows the value of trading activity during the session without implying any underlying motive. In a micro cap name like AVIENCE BIOMEDICALS LTD, such a move can attract attention simply because the price change is large relative to company size. Still, the data supplied here does not allow a reasoned claim about why the stock moved. The only supported conclusion is that AVIENCE BIOMEDICALS Share Price saw a sharp intraday rise, held its gains, and closed at the peak of the session range.

From a market narrative perspective, the combination of a higher open than the previous close, a lower intraday low of Rs 333, and a finish at Rs 376.25 gives a useful snapshot of how the session evolved. The stock showed enough volatility to move across a broad range, but the final settlement at the day high is the key point for event-based readers. When a stock closes at its best level of the day, it often becomes the centre of attention in today’s movers list, and that is exactly the kind of factual prominence the day’s action suggests for AVIENCE BIOMEDICALS Share Price Today.

For investors following short-term market screens, the message is straightforward. The session was strong, the move was decisive, and the closing price confirmed the gains. What cannot be added, however, is a motive. No earnings update, regulatory development, business announcement or sector-wide event has been supplied in the source data. So while AVIENCE BIOMEDICALS Stock News clearly reflects a price rise, the interpretation must stop at the verified trade action and not move into unsupported explanation.

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 187.62 crore
P/E Ratio	21.43x
P/B Ratio	3.54x
ROE	49.9%
ROCE	34.16%
EPS	Rs 15.96
Book Value Per Share	Rs 96.66
Dividend Yield	0%

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) fundamental metrics show P/E 21.43x, P/B 3.54x, ROE 49.9%, ROCE 34.16%. These figures provide context only and are not a buy or sell signal.

AVIENCE BIOMEDICALS LTD has a market capitalisation of Rs 187.62 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 21.43x, P/B at 3.54x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 49.9% and ROCE of 34.16%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 15.96, book value per share of Rs 96.66, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 35.6x, median ROE of 13.4%, median ROCE of 14.55%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Medical Equipment/Supplies/Accessories
Benchmark Scope	same industry
Company P/E Ratio	21.43x
Benchmark Median P/E	35.6x
Benchmark Average P/E	92.27x
Benchmark P/E Range	7.52x to 1,051.05x
Company P/B Ratio	3.54x
Benchmark Median P/B	3.61x
Company ROE	49.9%
Benchmark Median ROE	13.4%
Company ROCE	34.16%
Benchmark Median ROCE	14.55%
Company Market Capitalisation	Rs 187.62 crore
Benchmark Median Market Cap	Rs 183.21 crore

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a P/E ratio of 21.43x, which is below the benchmark median of 35.6x, a difference of -39.8%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a ROE of 49.9%, which is above the benchmark median of 13.4%, a difference of +272.39%. AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a ROCE of 34.16%, which is above the benchmark median of 14.55%, a difference of +134.78%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
LENSKART SOLUTIONS LTD	LENSKART	1,18,325	180.55	13.23	6.85	12.55
Poly Medicure Ltd.	POLYMED	17,477.76	55.47	5.49	10.94	14.05
Q-LINE BIOTECH LIMITED	QLINE	1,559.37	27.99	3.19	25.55	22.23
3B Blackbio Dx Ltd.	3BBLACKBIO	1,256.07	22.62	4.49	19.41	26.03
LAXMI DENTAL LIMITED	LAXMIDENTL	1,099.49	35.6	4.48	11.95	13.29

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a P/E ratio of 21.43x compared with the displayed peer median of 35.6x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 49.9% compares with a peer median of 11.95% across the companies shown in the table. ROCE stood at 34.16% versus the displayed peer median of 14.05%, providing a capital-efficiency comparison. AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a market capitalisation of Rs 187.62 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching AVIENCE BIOMEDICALS

• AVIENCE BIOMEDICALS Share Price rose 10.00% today, from Rs 342.05 to Rs 376.25.
• The stock closed at the day high of Rs 376.25 after opening at Rs 346.00.
• Market capitalisation is Rs 187.62 crore, close to the supplied industry median.
• P/E at 21.43 and P/B at 3.54 are below or near the benchmark medians.
• ROE of 49.9% and ROCE of 34.16% are above the supplied benchmark levels.

About AVIENCE BIOMEDICALS LTD

AVIENCE BIOMEDICALS LTD belongs to the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. Within that classification, the supplied data does not provide product-level detail, segment split or revenue composition, so the company profile must remain limited to the verified sector tags. That is still useful because industry grouping matters when readers compare AVIENCE BIOMEDICALS Share Price with peers that operate in the same specialised healthcare basket.

For a company in this category, valuation and profitability are often discussed together. AVIENCE BIOMEDICALS has supplied return ratios that are higher than the benchmark medians, while its market capitalisation is near the benchmark median and its P/E is below the median. Those facts give context to the stock’s market performance today, but they do not extend beyond the data provided. This keeps the article factual and prevents unsupported business detail from being added to the AVIENCE BIOMEDICALS Stock News update.

Track AVIENCE BIOMEDICALS Share Price on Univest

Use AVIENCE BIOMEDICALS LTD (AVIENCE-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track AVIENCE BIOMEDICALS Share Price on Univest for live market updates, valuation details and sector context. The stock page brings the latest price information into one place, while broader market screens help users compare today’s move with other gainers and the wider healthcare peer universe. That makes it easier to follow the stock after a sharp daily rise and revisit the same factual points as new market data comes in.

Frequently Asked Questions

Why did AVIENCE BIOMEDICALS Share Price rise today?

Ans. The supplied data confirms a 10.00% rise in AVIENCE BIOMEDICALS Share Price, but it does not identify any specific corporate or market catalyst. The update should therefore be read as a verified price move, not an explained event.

What is AVIENCE BIOMEDICALS Share Price Today?

Ans. AVIENCE BIOMEDICALS Share Price Today is Rs 376.25. It rose Rs 34.20, or 10.00%, from the previous close of Rs 342.05 and ended the session at the day high. That is the verified closing figure.

What is the market capitalisation of AVIENCE BIOMEDICALS LTD?

Ans. AVIENCE BIOMEDICALS LTD has a market capitalisation of Rs 187.62 crore. In the supplied industry benchmark, that is close to the median company size, which helps place the stock within its healthcare peer group.

How does AVIENCE BIOMEDICALS compare with its industry benchmarks?

Ans. AVIENCE BIOMEDICALS has a P/E of 21.43 and P/B of 3.54, both around or below the supplied benchmark medians. Its ROE of 49.9% and ROCE of 34.16% are above the benchmark medians.

How should investors read today’s price rise?

Ans. The best reading is factual and cautious. The stock had a strong session, closed at the high, and showed notable relative strength. However, the source data does not support assigning a reason for the move.

Can AVIENCE BIOMEDICALS Share Price be compared with peers?

Ans. Yes. The supplied peer set shows AVIENCE BIOMEDICALS is much smaller than several listed peers, while its ROE and ROCE are higher than the figures shown for the companies in the comparison table. That gives useful relative context.